Antigen-specific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly(DL-lactide-co-glycolide) microspheres

Vaccine

Volumn 21, Issue 27-30, 2003, Pages 4472-4480

  Kavanagh, Owen V ^a   Earley, Bernadette ^b   Murray, Margaret ^b   Foster, Colin J ^c   Adair, Brian M ^a,c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b GRANGE RESEARCH CENTRE   (Ireland)

^c AGRI FOOD AND BIOSCIENCES INSTITUTE   (United Kingdom)

Author keywords

Flow cytometric analysis; Ovalbumin; Poly(DL lactide co glycolide) microspheres

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICROSPHERE; OVALBUMIN; POLYGLACTIN;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CATTLE; CONTROLLED STUDY; DISPERSION; DRUG BLOOD LEVEL; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOGENICITY; INOCULATION; MICROENCAPSULATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0348078301     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00432-8     Document Type: Article

References (32)

1. Radostits O.M. The control of infectious diseases of the respiratory and digestive tracts of cattle. Can. Vet. J. 32:1991;85-89.
2. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Rice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release. 11:1990;205-214.
3. Alpar H.O., Almeida A.J., Brown M.R.W. Microsphere absorption by nasal mucosae of the rat. J. Drug Target. 2:1994;147-149.
4. Heritage P.L., Brook M.A., Underdown B.J., McDermott M.R. Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes. Immunology. 93:1998;249-256.
5. Maloy K.J., Donachie A.M., O'Hagan D.T., Mowat A.M. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. Immunology. 81:1994;661-667.
6. Eyles J.E., Sharp G.J.E., Williamson E.D., Spiers I.D., Alpar H.O. Intranasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine. 16:1998;698-707.
7. Shephard M.J., Todd D., Adair B.M., Li Wan Po A., Mackie D.P., Scott E.M. Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice. Res. Vet. Sci. 74:2003;187-190.
8. Gilding D.K., Reed A.M. Biodegradable polymers for use in surgery: poly(glycolic)/poly(lactic) acid homo- and copolymers. Polymer. 20:1979;1459-1464.
9. Brayden D.J., O'Mahony D.J. Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines. Pharm. Sci. Technol. Today. 1:1998;291-299.
10. Rebelatto M.C., Guimond P., Bowersock T.L., HogenEsch H. Induction of systemic and mucosal immune responses in cattle by intranasal administration of pig serum albumin in alginate microparticles. Vet. Immunol. Immunopathol. 83:2001;93-105.
11. Jeffery H., Davis S.S., O'Hagan D.T. The preparation and characterisation of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 10:1993;362-368.
12. Bryson D.G., McFerran J.B., Ball H.J., Neill S.D. Observations on outbreaks of respiratory disease in calves associated with parainfluenza type 3 virus and respiratory syncytial virus. Vet. Rec. 104:1979;45-49.
13. Adair B.M., Bradford H.E.L., Bryson D.G., Foster J.C., McNulty M.S. Effect of parainfluenza-3 virus challenge on cell-mediated immune function in parainfluenza-3 vaccinated and non-vaccinated calves. Res. Vet. Sci. 68:2000;197-199.
14. Kimman T.G., Sol J., Westenbrink F., Straver P.J. A severe outbreak of respiratory disease associated with BRSV probably enhanced by vaccination with a modified live virus. Vet. Q. 11:1989;250-253.
15. Gershwin L.J., Woolums A.R., Gunther R.A., Anderson M.L., LaRochelle D.R.B.G.A., Friebertshauser K.E.et al. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology. Vaccine. 16:1998;1225-1236.
16. Mazanac M.B., Nedrud J.G., Kaetzel C.S., Lamm M.E. A three-tiered view of the role of IgA in mucosal defense. Immunol. Today. 14:1993;430-434.
17. Weltzin R., Traina-Dorge K., Soike K., Zhang J.-Y., Mack P., Soman G.et al. Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection. J. Infect. Dis. 74:1996;256-261.
18. Singh M., Li X.M., Wang H.Y., McGee J.P., Zamb T., Koff W.et al. Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models. Vaccine. 16:1998;346-352.
19. Offit P.A., Clarke H.F. Protection against rotavirus-induced gastroenteritis in a murine model by passively acquired gastrointestinal but not circulating antibodies. J. Virol. 54:1985;58-64.
20. Weltzin R., Monath T.P. Intranasal antibody prophylaxis for protection against viral diseases. Clin. Microbiol. Rev. 12:1999;383-387.
21. Anderson M.L., Moore P.F., Hyde D.M., Dungworth D.L. Bronchus-associated lymphoid tissue in the lungs of cattle: relationship to age. Res. Vet. Sci. 41:1986;211-220.
22. Scuh J.C.L., Oliphant L.W. Development and immunophenotyping of the pharyngeal tonsil (adenoid) in cattle. J. Comp. Pathol. 106:1992;229-241.
23. Eldridge J.H., Staas J.K., Meulbroek J.A., McGhee J.R., Tice T.R., Gilley R.M. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 28:1991;287-294.
24. Maloy K.J., Donachie A.M., O'Hagan D.T., Mowat A.M. Induction of mucosal and systemic immune responses by immunisation with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles. J. Immunol. 81:1994;661-667.
25. O'Hagan D.T., Jeffery H., Davis S.S. Long term antibody responses in mice following subcutaneous immunisation with ovalbumin entrapped in biodegradable microparticles. Vaccine. 11:1993;965-969.
26. O'Hagan D.T., Ugozzoli M., Barackman J., Singh M., Kazzaz J., Higgins K.et al. Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1. Vaccine. 18:2000;1793-1801.
27. Johansen P., Gander B., Merkle H.P., Sesardic D. Ambiguities in the preclinical quality assessment of microparticulate vaccines. Trends Biotechnol. 18:2000;203-211.
28. Men Y., Audran R., Thomasin C., Eberl G., Demotz S., Merkle H.P.et al. MHC class I- and II-restricted processing and presentation of microencapsulated antigens. Vaccine. 17:1999;1047-1056.
29. McInnes E., Sopp P., Howard C.J., Taylor G. Phenotypic analysis of local cellular responses in calves infected with bovine respiratory syncytial virus. Immunology. 96:1999;396-403.
30. Bamford A.I., Adair B.M., Foster J.C. Primary cytotoxic response of bovine peripheral blood leukocytes to parainfluenza type 3 virus infected cells. Vet. Immunol. Immunopathol. 45:1995;85-95.
31. Hilbert A.K., Fritzsche U., Kissel T. Biodegradable microspheres containing influenza A vaccine: immune response in mice. Vaccine. 17:1999;1065-1073.
32. Gray D., Skarvall H. B-cell memory is short lived in the absence of antigen. Nature. 336:1988;70-73.